386 related articles for article (PubMed ID: 27760050)
21. Upregulation of miR-497 induces hepatic insulin resistance in E3 rats with HFD-MetS by targeting insulin receptor.
Wang X; Wang M; Li H; Lan X; Liu L; Li J; Li Y; Li J; Yi J; Du X; Yan J; Han Y; Zhang F; Liu M; Lu S; Li D
Mol Cell Endocrinol; 2015 Nov; 416():57-69. PubMed ID: 26300412
[TBL] [Abstract][Full Text] [Related]
22. Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance.
Qiu Y; Sui X; Zhan Y; Xu C; Li X; Ning Y; Zhi X; Yin L
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):978-990. PubMed ID: 28153708
[TBL] [Abstract][Full Text] [Related]
23. Missense variant in insulin receptor (Y1355H) segregates in family with fatty liver disease.
Luo F; Xing C; Asrani SK; Li S; Liang G; Hobbs HH; Cohen JC
Mol Metab; 2021 Nov; 53():101299. PubMed ID: 34271222
[TBL] [Abstract][Full Text] [Related]
24. Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease.
Parks E; Yki-Järvinen H; Hawkins M
J Clin Invest; 2017 Feb; 127(2):454-456. PubMed ID: 28112684
[TBL] [Abstract][Full Text] [Related]
25. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
26. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
[TBL] [Abstract][Full Text] [Related]
28. MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels.
Nagarajan A; Petersen MC; Nasiri AR; Butrico G; Fung A; Ruan HB; Kursawe R; Caprio S; Thibodeau J; Bourgeois-Daigneault MC; Sun L; Gao G; Bhanot S; Jurczak MJ; Green MR; Shulman GI; Wajapeyee N
Nat Commun; 2016 Aug; 7():12639. PubMed ID: 27577745
[TBL] [Abstract][Full Text] [Related]
29. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha.
Goren I; Müller E; Pfeilschifter J; Frank S
Am J Pathol; 2006 Mar; 168(3):765-77. PubMed ID: 16507892
[TBL] [Abstract][Full Text] [Related]
30. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
[TBL] [Abstract][Full Text] [Related]
31. Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes.
Min KH; Yang WM; Lee W
Biochem Biophys Res Commun; 2018 Sep; 503(3):1587-1593. PubMed ID: 30033101
[TBL] [Abstract][Full Text] [Related]
32. Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways.
Zhang F; Zhang Z; Kong D; Zhang X; Chen L; Zhu X; Lu Y; Zheng S
Mol Cell Endocrinol; 2014 Jan; 382(1):197-204. PubMed ID: 24071517
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis.
Qin W; Weng J
Sci Bull (Beijing); 2023 Jul; 68(13):1413-1429. PubMed ID: 37336688
[TBL] [Abstract][Full Text] [Related]
34. Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1.
Yang WM; Min KH; Lee W
PLoS One; 2016; 11(12):e0169039. PubMed ID: 28036389
[TBL] [Abstract][Full Text] [Related]
35. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis.
Xu H; Zhou Y; Liu Y; Ping J; Shou Q; Chen F; Ruo R
J Endocrinol; 2016 May; 229(2):133-44. PubMed ID: 26941037
[TBL] [Abstract][Full Text] [Related]
36. Effect of spontaneous gestational diabetes on fetal and postnatal hepatic insulin resistance in Lepr(db/+) mice.
Yamashita H; Shao J; Qiao L; Pagliassotti M; Friedman JE
Pediatr Res; 2003 Mar; 53(3):411-8. PubMed ID: 12595588
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.
Abdelmoemen G; Khodeir SA; Zaki AN; Kassab M; Abou-Saif S; Abd-Elsalam S
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):185-188. PubMed ID: 30009716
[TBL] [Abstract][Full Text] [Related]
38. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin reduces lipid accumulation in the liver by activating protein kinase A-mediated phosphorylation of perilipin 5.
Gao X; Nan Y; Zhao Y; Yuan Y; Ren B; Sun C; Cao K; Yu M; Feng X; Ye J
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Dec; 1862(12):1512-1519. PubMed ID: 28919478
[TBL] [Abstract][Full Text] [Related]
40. Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice.
Abulizi A; Camporez JP; Zhang D; Samuel VT; Shulman GI; Vatner DF
Metabolism; 2019 Apr; 93():1-9. PubMed ID: 30576689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
